Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study.

Source:http://linkedlifedata.com/resource/pubmed/id/6688199

Download in:

View as

General Info

PMID
6688199